Pharma Reviews: New IPR policy to benefit MSMEs pharma sector with innovation: Dr Gopakumar Nair

Medium and small scale pharma units in India need to update themselves to survive in changing regulatory and intellectual property environment.
Read more: New IPR policy to benefit MSMEs pharma sector with innovation: Dr Gopakumar Nair